peptideNot FDA-approvedSold as a cosmetic ingredient, not as a drug or dietary supplement, in most jurisdictions
ArgirelineBenefits, Dosage & Interactions
Also known as: Acetyl Hexapeptide-8
Argireline, chemically known as acetyl hexapeptide-8, is a synthetic peptide derived from a naturally occurring protein. It consists of six amino acids and is primarily lauded in the cosmetic industry for its potential to reduce the appearance of fine lines and wrinkles.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Strong — 1 human randomized trial published.
Evidence strengthStrong · 4/4
PreclinicalStrong human evidence
1 human randomized trial published.
Plasma half-life
Not established for topical use; the peptide acts locally at the neuromuscular junction
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- The published efficacy trial used a topical cream containing 10% acetyl hexapeptide-3/8 (Argireline) solution[1][2]
Reported for Argireline in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Argireline entry is written from. Each number matches an inline marker above.
- [1]A synthetic hexapeptide (Argireline) with antiwrinkle activityBlanes-Mira C, Clemente J, Jodas G, Gil A, Fernández-Ballester G, Ponsati B, Gutierrez L, Pérez-Payá E, Ferrer-Montiel A · International Journal of Cosmetic Science · 2002 · Peer-reviewed · PMID 18498523
- [2]The anti-wrinkle efficacy of ArgirelineWang Y, Wang M, Xiao XS, Huo J, Zhang WD · Journal of Cosmetic and Laser Therapy · 2013 · Peer-reviewed · PMID 23464592
- [3]Cosmeceuticals in photoaging: A reviewChan LKW, Lee KWA, Lee CH, Lam KWP, Lee KFV, Wu R, Wan J, Shivananjappa S, Sky WTH, Choi H, Yi KH · Skin Research and Technology · 2024 · Peer-reviewed · PMID 39233460
How to track Argireline doses
Argireline is tracked as a protocol rather than a single reminder: a vial with a concentration, a schedule that may be titrated or cycled, and a rotation of injection sites. Here is the record that keeps all three consistent.
- 1
Record the vial and concentration
Log the vial strength and the volume of bacteriostatic water you added so Argireline is stored as a concentration rather than a guess. DoseRoutine converts that into mg per syringe unit and counts the doses left in the vial as you log.
- 2
Set the schedule, not just a reminder
Enter the dose in mg and the frequency. Cycled protocols get a start and end date so the history stays accurate when Argireline comes out of the routine.
- 3
Rotate and log the injection site
Pick the site at the moment you log the dose. The site map shows what you used last and how recently, which is the part that drifts fastest when two compounds run on different frequencies.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
Review Argireline alongside your logged metrics and any relevant blood work every few weeks before changing the dose, so the change is a response to data rather than to a good or bad day.
What to log each time
- Dose in mg and the syringe units it worked out to
- Vial: reconstitution date, concentration, doses remaining
- Injection site and time
- Any side effects in the 24 h after the dose
References & Evidence
Sources on this page that document Argireline dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Argireline studied for?
What is Argireline?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Argireline, chemically known as acetyl hexapeptide-8, is a synthetic peptide derived from a naturally occurring protein. It consists of six amino acids and is primarily lauded in the cosmetic industry for its potential to reduce the appearance of fine lines and wrinkles. Unlike some other cosmetic interventions, Argireline is applied topically to the skin. Its chemical structure is designed to mimic a portion of the SNAP-25 protein, which plays a role in neurotransmitter release. First introduced in the early 2000s, it has become a staple ingredient in many anti-aging skincare formulations (PubChem, DrugBank).
The compound is typically found in serums, creams, and other topical skincare products. It is not an injectable substance and its application is restricted to the skin's surface. Its use is generally focused on areas prone to expression lines, such as the forehead, around the eyes, and mouth. As a relatively small peptide, it is theoreticalized to be able to penetrate the stratum corneum, the outermost layer of the skin, to exert its effects. However, the extent of its skin penetration and bioavailability are subjects of ongoing research within the scientific community.
What does the research say about Argireline?
Tap a section to expand.
Argireline's proposed mechanism of action involves interfering with the SNARE complex, a protein complex essential for the release of neurotransmitters at the neuromuscular junction. Specifically, Argireline is posited to act as a SNAP-25 mimetic, competing with the genuine SNAP-25 protein for a position within the SNARE complex. By destabilizing or disrupting the formation of the SNARE complex, it is theorized that Argireline can reduce the efficiency of acetylcholine release from the nerve endings.
In turn, a reduction in acetylcholine release could lead to a decrease in muscle contraction. For facial muscles, which are largely responsible for expression lines and wrinkles, a subtle and localized reduction in contraction could theoretically lessen the appearance of dynamic wrinkles. This mechanism is often compared to the effects of botulinum toxin (Botox), though Argireline's action is generally considered far milder, superficial, and non-paralytic. Unlike botulinum toxin, which cleaves SNAP-25, Argireline is believed to modulate its function. It is important to note that most of the research supporting this mechanism comes from in vitro studies and theoretical modeling, with in vivo evidence still under investigation (Examine.com, DrugBank).
Source for this section: Sources for How does Argireline work?: Jumps to this entry in the sources and references list at the end of the page.
The primary benefit associated with Argireline is the potential reduction in the appearance of expression lines and wrinkles. Users and cosmetic manufacturers often report improvements in skin smoothness and a more youthful complexion. Specifically, the peptide is marketed for its ability to target lines caused by repetitive facial muscle movements, such as crow's feet, forehead lines, and frown lines (Examine.com).
Studies, primarily conducted by manufacturers or independent research groups, have explored the topical application of Argireline-containing formulations. These studies often report observed decreases in wrinkle depth and length over several weeks of consistent use. For instance, some research suggests a measurable, albeit modest, improvement in wrinkle parameters compared to placebo. It is crucial to understand that these benefits are typically aesthetic, temporary, and dependent on continuous application. Argireline does not address other aspects of skin aging, such as sun damage, collagen loss, or hyperpigmentation, directly (Manufacturer research reports, independent cosmetic science evaluations).
Evidence for Argireline's efficacy predominantly stems from in vitro studies, animal models, and human clinical trials conducted by or connected to its manufacturers. A common finding in these studies is a statistically significant, though often modest, reduction in wrinkle depth and length when compared to a placebo. For example, some human trials have reported a reduction in wrinkle volume or depth by a certain percentage after a specified period of topical application (e.g., 28 days) (Cosmetic ingredient supplier studies).
However, independent, peer-reviewed research from academic institutions, particularly large-scale, long-term studies, is less abundant. While the theoretical mechanism of action is plausible based on its peptide structure, the extent to which topical application translates to significant, deep-dermal changes in human skin in a real-world setting continues to be a subject of scientific discussion (Examine.com). Regulatory bodies like the FDA in the United States do not classify Argireline as a drug, but rather as a cosmetic ingredient, meaning it is not subjected to the same rigorous efficacy and safety testing as pharmaceuticals.
Argireline is generally considered to be well-tolerated when applied topically. Reported side effects are rare and typically mild, often associated with the formulation ingredients rather than the peptide itself. Potential side effects can include:
* Localized skin irritation, such as redness or itching, especially in individuals with sensitive skin.
* Contact dermatitis or allergic reactions, though infrequent.
* Dryness or flakiness, which might be due to other active ingredients or excipients in the product.
Because Argireline's proposed mechanism involves relaxing facial muscles, some users have anecdotally reported a sensation of muscle relaxation; however, this is not a scientifically confirmed or commonly reported side effect. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
While generally safe for topical cosmetic use, a few warnings are prudent. As with any skincare product, a patch test on a small area of skin (e.g., behind the ear or inside the wrist) is recommended before applying Argireline-containing products to the entire face, especially for individuals with a history of skin sensitivities or allergies. Discontinue use if irritation, redness, or discomfort occurs and persists. Avoid direct contact with eyes. If contact occurs, rinse eyes thoroughly with water.
There is limited research on the use of Argireline in pregnant or breastfeeding individuals. Therefore, it is generally advised to consult a healthcare professional before using such products during these periods. The long-term effects of daily application over many years are also not extensively studied. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
There are no absolute medical contraindications for the topical use of Argireline widely established in the scientific literature, beyond individual sensitivities to the ingredient itself or other components within a product formulation. People with known allergies to any peptides or ingredients commonly found in cosmetic preparations should exercise caution. Individuals with active skin conditions like eczema, rosacea, or open wounds on the application areas should avoid use until the condition resolves, as the product could potentially exacerbate irritation or interfere with healing. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Based on current scientific understanding and its topical application, there are no well-documented harmful interactions or 'do not mix' recommendations for Argireline with other specific cosmetic ingredients or oral medications. However, common skincare practice advises caution when combining many different active ingredients simultaneously, particularly those that can cause exfoliation or irritation (e.g., high-strength retinoids, alpha hydroxy acids). Combining multiple potent cosmetic ingredients without professional guidance might increase the risk of skin irritation. If using multiple targeted treatments, it is often suggested to introduce them gradually or use them at different times of the day to monitor skin response. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Argireline can typically be applied at any time of day. Most skincare routines incorporate it once or twice daily, commonly in the morning and/or evening. It is usually applied after cleansing and toning, but before heavier creams or sunscreens. Its half-life in the context of topical skin absorption is not precisely defined, but its effects are generally considered to be somewhat acute and temporary, necessitating consistent daily use for sustained cosmetic benefit. There are no dietary restrictions or specific food rules associated with its topical application. Individual needs vary — talk to a licensed clinician.
Source for this section: Sources for When should you take Argireline?: Jumps to this entry in the sources and references list at the end of the page.
What interacts with Argireline?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any peptide + hormone | Note | Category ruleConfidence: theoretical | Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.Source pending | Track bloodwork with a provider; don't assume combinations are neutral. |
Frequently asked questions about Argireline
Argireline (Acetyl Hexapeptide-8) is a synthetic peptide used in cosmetic products to help reduce the appearance of fine lines and wrinkles, particularly those caused by repetitive facial expressions.
Argireline is theorized to work by interfering with the SNARE complex, which is involved in neurotransmitter release, thereby subtly relaxing facial muscle contractions that contribute to dynamic wrinkles. Its effect is milder and more superficial than injectable treatments.
Results typically vary among individuals and depend on the concentration of Argireline in the product and consistency of use. Some studies suggest visible improvements may be observed after 2 to 4 weeks of consistent twice-daily application, with more pronounced benefits after longer periods.
Argireline is generally considered safe for topical cosmetic use, with a low incidence of side effects like mild skin irritation. As with any cosmetic ingredient, a patch test is recommended before widespread use. It is not classified as a drug by regulatory bodies.
As a peptide, Argireline can overlap with other supplements, prescription medicines, hormones and peptides. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Argireline with no sign-up.
Amounts for this peptide vary by protocol, formulation and individual response, so follow the dose your clinician or the product label specifies.
Whether Argireline fits alongside testosterone replacement therapy depends on the protocol — dose, ester and ancillaries such as HCG or anastrozole — and on current bloodwork. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
"Peptides" is not one category — healing peptides, GLP-1 agonists, growth-hormone secretagogues and melanocortins each behave differently next to Argireline. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for Argireline varies by protocol and formulation, so the label or prescription is what sets it. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of Argireline depends on the protocol and formulation you are on. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Argireline the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Which studies looked at Argireline?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study(opens PubMed in a new tab)Am J Clin Dermatol · 2013 · PMID 23417317 · https://pubmed.ncbi.nlm.nih.gov/23417317/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 71587772(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/71587772
Verify at
Publisher search links for Argireline. These are places to check the information — they are not citations, so they are not numbered.
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- Examine.com(publisher search, opens in a new tab)Examine.com · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- DailyMed labeling archive(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Argireline?
Plain-text summary, safe to quote verbatim:
Argireline, chemically known as acetyl hexapeptide-8, is a synthetic peptide derived from a naturally occurring protein. It consists of six amino acids and is primarily lauded in the cosmetic industry for its potential to reduce the appearance of fine lines and wrinkles.
Source: DoseRoutine — https://doseroutine.com/library/argireline
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Argireline — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/argireline
What compounds are similar to Argireline?
Others in the peptide category or studied for the same goals.
Which goals is Argireline used for?
Other compounds studied for the same benefits as Argireline.
Continue exploring
See every compound DoseRoutine catalogs for these goals.